about
Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.Immune therapy for human papillomaviruses-related cancers.Development of therapeutic HPV vaccines.Anal warts and anal intradermal neoplasia.Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease.Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarraysCombining radiotherapy and immunotherapy: a revived partnership.Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controlsDepot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infectionTherapeutic vaccines against human papillomavirus and cervical cancer.Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia.Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model.Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape.Prevalence of human papillomavirus infection in women in Busan, South Korea
P2860
Q34310582-2FF62369-6CFE-489C-9119-C1B7C692CB8DQ34657561-84C38647-556D-4209-B59C-99C858E0F4DDQ34953499-06A76D9C-66DC-48D9-80BA-17DC551DEAB0Q35117953-6A26BE7A-CC87-4F9C-A802-05FC9FB773BFQ35144042-665ADFAA-8320-4E8F-A857-BF73F967006FQ35211033-42D086E4-74A3-421D-A2EC-F76863D2B198Q35789859-071783F4-9B2B-472F-BEC8-23AC0A436AA3Q36274581-B16EF8F9-6E93-47B2-AEBA-88C90FEBEF8BQ36992568-B3024017-D632-4ED5-9BA4-FEBDA7E7FDA4Q37267830-0630E839-5BD5-437E-801A-D5F07D9F85A9Q37418916-55E855AF-CA6B-4FE8-AE3B-FBBFDC9337CCQ37426794-F25832E0-7CD0-4250-BA8B-45833FC09C5AQ38687539-2B88DD59-02C2-4433-982C-9DBDCEFD0460Q53519290-916369C3-820D-4D25-999A-37D8A7E6BB31Q54515558-B99E2CC4-7B31-4876-95D6-1E44EE893D50Q57216236-948DADC1-373F-4EB4-819D-34AD11DFE325
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunity to oncogenic human papillomaviruses.
@ast
Immunity to oncogenic human papillomaviruses.
@en
Immunity to oncogenic human papillomaviruses.
@nl
type
label
Immunity to oncogenic human papillomaviruses.
@ast
Immunity to oncogenic human papillomaviruses.
@en
Immunity to oncogenic human papillomaviruses.
@nl
prefLabel
Immunity to oncogenic human papillomaviruses.
@ast
Immunity to oncogenic human papillomaviruses.
@en
Immunity to oncogenic human papillomaviruses.
@nl
P1476
Immunity to oncogenic human papillomaviruses.
@en
P2093
P304
P356
10.1016/S0065-230X(01)82007-8
P577
2001-01-01T00:00:00Z